The Allergists’ Foundation’s success in 2024
Together we can grow the program and support projects that make a difference for our specialty, our patients and our communities.
Guidance for payers related to unreasonable documentation for immunotherapy
Read our easy-to-use summary sheet of guidance for payers re reasonable and unreasonable requests for 95165 documentation.
FDA proposes phenylephrine removal from oral OTC drugs
Only a final order will affect which products may be marketed. The proposed order is based on effectiveness concerns, not on safety concerns.
We’ve come a long way
This year, much of our advocacy effort has been devoted to influencing changes to the 2025 Proposed Medicare Physician Fee Schedule.
New guidance for payers related to unreasonable documentation for immunotherapy
The recommendations lay out what the authors see as reasonable and unreasonable requests for documentation for allergy immunotherapy services.
November issue of Annals focuses on COVID-19 and its long-term effects
The November issue of Annals of Allergy, Asthma & Immunology is focused on COVID-19 and its long-term effects.
2025 Medicare PFS final rule results in pay cut for allergists
It’s official: allergists will receive a huge Medicare payment reduction unless Congress acts to prevent these cuts from taking effect.
A successful 2024 Annual Scientific Meeting in Boston
Media covered topics ranging from anaphylaxis treatment, efficacy of elimination diets for atopic dermatitis, risk of developing EoE and penicillin allergy del…
Meet the 2024-25 College President
At the 2024 Annual Scientific Meeting in Boston, James Tracy, DO, FACAAI was installed as the 2024-25 College president.
ACAAI FIT Bowl
The ACAAI Fit Bowl is patterned after a popular TV quiz show. Teams representing programs from all over North America compete for the coveted FIT Bowl trophy. …